CARDIOVASCULAR SAFETY OF BCR-ABL1 TYROSINE KINASE INHIBITORS: IMATINIB AND PONATINIB DECREASE PLASMA CHOLESTEROL AND ATHEROSCLEROSIS IN APOE3*LEIDEN.CETP MICE
Author(s):
Pouwer, M.; Pieterman, E.; Verschuren, L.; Caspers, M.; Kluft, K.; Garcia, R.; Lee, F.; Aman, J.; Jukema, W.; Princen, H.